Abstract
Amphibians have been favored organisms by experimental embryologists for more than a century. Their large, resilient embryos are ideal for manipulations, such as tissue transplantation, explantation and recombination, methods that have been used to demonstrate the existence and location of inducing centers in developing embryos and to define important embryological principles. Molecular biological approaches developed primarily in Xenopus, including a highly efficient method for transgenesis, have provided another dimension to our understanding of a multitude of cellular and developmental problems. Although there have been many developmental mutants reported in amphibians, mainly in axolotl and Xenopus laevis, amphibians have not been as widely used for genetic approaches as other vertebrates, like the mouse and zebrafish. This has been in part because of the long generation time of these species and their large genome size, especially in the case of axolotl. The duplicated genome of X. laevis also presents potential limitations. But another factor mitigating use of these systems for genetics in past times has been the lack of complementary techniques for studying mutants in detail at the molecular level. A more recently introduced model, Xenopus tropicalis, offers an array of new opportunities for genetic studies. Its short generation time and smaller, diploid genome, together with accumulating genomic resources, make X. tropicalis a very attractive model organism for addressing complex issues in modern cell and developmental biology. Here we will introduce the main features of the X. tropicalis system and briefly discuss possible methodologies for isolating developmental mutants for genetic studies.
Keywords: developmental mutant, genetic screens, genomics, gynogenesis, mutagenesis
Current Genomics
Title: Generation and Characterization of Developmental Mutations in Xenopus tropicalis
Volume: 4 Issue: 8
Author(s): Takuya Nakayama and Robert M. Grainger
Affiliation:
Keywords: developmental mutant, genetic screens, genomics, gynogenesis, mutagenesis
Abstract: Amphibians have been favored organisms by experimental embryologists for more than a century. Their large, resilient embryos are ideal for manipulations, such as tissue transplantation, explantation and recombination, methods that have been used to demonstrate the existence and location of inducing centers in developing embryos and to define important embryological principles. Molecular biological approaches developed primarily in Xenopus, including a highly efficient method for transgenesis, have provided another dimension to our understanding of a multitude of cellular and developmental problems. Although there have been many developmental mutants reported in amphibians, mainly in axolotl and Xenopus laevis, amphibians have not been as widely used for genetic approaches as other vertebrates, like the mouse and zebrafish. This has been in part because of the long generation time of these species and their large genome size, especially in the case of axolotl. The duplicated genome of X. laevis also presents potential limitations. But another factor mitigating use of these systems for genetics in past times has been the lack of complementary techniques for studying mutants in detail at the molecular level. A more recently introduced model, Xenopus tropicalis, offers an array of new opportunities for genetic studies. Its short generation time and smaller, diploid genome, together with accumulating genomic resources, make X. tropicalis a very attractive model organism for addressing complex issues in modern cell and developmental biology. Here we will introduce the main features of the X. tropicalis system and briefly discuss possible methodologies for isolating developmental mutants for genetic studies.
Export Options
About this article
Cite this article as:
Nakayama Takuya and Grainger M. Robert, Generation and Characterization of Developmental Mutations in Xenopus tropicalis, Current Genomics 2003; 4 (8) . https://dx.doi.org/10.2174/1389202033490123
DOI https://dx.doi.org/10.2174/1389202033490123 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in Targeted Anti-Vasculature Therapy: The Neuroblastoma Model
Current Drug Targets Applications and Toxicity of Silver Nanoparticles: A Recent Review
Current Topics in Medicinal Chemistry A Decade of Targets and Patented Drugs for Chemotherapy of Chagas Disease
Recent Patents on Anti-Infective Drug Discovery Rheumatoid Arthritis: An Evolutionary Force in Biologics
Current Pharmaceutical Design ATP Synthase: A Molecular Therapeutic Drug Target for Antimicrobial and Antitumor Peptides
Current Medicinal Chemistry Parvovirus B19 (B19V) Infection and Pregnancy
Current Pediatric Reviews The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Is Hospital Autopsy Auditing Suitable for Clinical Risk Manage ment? Actualities and Perspectives of Auditing in the Autopsy Room Following Italian Law 24/2017 on Patient Safety
Current Pharmaceutical Biotechnology Subject Index to Volume 10
Current Pharmaceutical Design The Prodigiosins: A New Family of Anticancer Drugs
Current Cancer Drug Targets The 21st Century Form of Vitamin E - Tocotrienol
Current Pharmaceutical Design Percutaneous Valve Interventions
Current Cardiology Reviews Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy
Current Cancer Drug Targets PI3K/Akt/JNK/c-Jun Signaling Pathway is a Mediator for Arsenite- Induced Cyclin D1 Expression and Cell Growth in Human Bronchial Epithelial Cells
Current Cancer Drug Targets AMPK as a Potential Anticancer Target - Friend or Foe?
Current Pharmaceutical Design Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences
Current Cardiology Reviews Physiology, Pharmacology and Pathophysiology of the pH Regulatory Transport Proteins NHE1 and NBCn1: Similarities, Differences, and Implications for Cancer Therapy
Current Pharmaceutical Design Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease
Current Topics in Medicinal Chemistry Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Current Cancer Drug Targets Developing Phytoestrogens for Breast Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry